mynth
11/2025

DESSINTEY acquired by ARLANE

FRANCE Life Sciences / Medical Devices REV 5M - 25M EUR

Context

Arlane has acquired a majority stake (approximately two-thirds) in Dessintey through a primary LBO. The transaction allows for the exit of early-stage investors Turenne Sante (via Relyens Innovation Sante) and Credit Agricole Haute-Loire, who invested in 2019. The three founders (Nicolas Fournier, Davy Luneau, Pascal Giraux) and key managers have reinvested alongside Arlane but are diluting their stakes. The deal is supported by a conservative senior debt package provided by CIC and LCL.

DESSINTEY, which reported an EBITDA margin of in 2025, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Dessintey is a French MedTech company specializing in intensive motor rehabilitation. It develops and markets intelligent devices aimed at patients recovering from strokes, trauma, or neurological disorders. Its technology typically uses visual illusion/simulation to stimulate brain plasticity. The company is profitable and present in France, Germany, Switzerland, and Austria.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2025
2024

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
12/2025MONTAGU PRIVATE EQUITY / KohlbergTeleflex Medical OEMUNITED STATESMedical Consumables
12/2025CHARTERHOUSEWINBACKFRANCEMedical Devices
11/2025ANJAC BEAUTY & HEALTHHEALTH CHAIN GROUP (HCG)SLOVENIACDMO
11/2025PFIZERMETSERAUNITED STATESR&D Biotech
10/2025PUBLIC MARKETS (IPO)OTTOBOCKGERMANYImplants & Prosthetics
09/2025INVESTCorporateDCC HEALTHCAREUNITED KINGDOMCDMO
09/2025CREDIT MUTUEL EQUITY / EURAZEO / BPIFRANCE / BNP PARIBAS DEVELOPPEMENTPROTEORFRANCEImplants & Prosthetics
09/2025CAPVEST PARTNERSSTADAGERMANYGenerics / Labs
09/2025HEARTLAND FOOD PRODUCTSSLIMFASTUNITED STATESNutrition & Dietary Supplements
08/2025WARBURG PINCUSSEBIAFRANCEDiagnostic Equipment

REFERENCES

Revenue range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DESSINTEY by ARLANE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: arlane